S
Studiengesellschaft BSF | Halle, Germany
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Irinotecan
Oxaliplatin
V565
Leucovorin
RO7198457
Vedolizumab
Upadacitinib
5-fluorouracil
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 6 total trials
This is a multi-site, open-label, Phase II, randomized, trial to compare the efficacy of RO7198457 versus watchful waiting in patients with circulati...
Enrolling
Colorectal Cancer Stage III
Colorectal Cancer Stage II
Drug: RO7198457 intravenous (IV)
Other: Observational group (no intervention)
The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel i...
Enrolling
Crohn's Disease
Drug: Vedolizumab
Drug: Placebo
Trial sponsors
V
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems